BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27623040)

  • 21. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
    Churchman ML; Qian M; Te Kronnie G; Zhang R; Yang W; Zhang H; Lana T; Tedrick P; Baskin R; Verbist K; Peters JL; Devidas M; Larsen E; Moore IM; Gu Z; Qu C; Yoshihara H; Porter SN; Pruett-Miller SM; Wu G; Raetz E; Martin PL; Bowman WP; Winick N; Mardis E; Fulton R; Stanulla M; Evans WE; Relling MV; Pui CH; Hunger SP; Loh ML; Handgretinger R; Nichols KE; Yang JJ; Mullighan CG
    Cancer Cell; 2018 May; 33(5):937-948.e8. PubMed ID: 29681510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
    Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
    Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
    Olsson L; Castor A; Behrendtz M; Biloglav A; Forestier E; Paulsson K; Johansson B
    Leukemia; 2014 Feb; 28(2):302-10. PubMed ID: 23823658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Dörge P; Meissner B; Zimmermann M; Möricke A; Schrauder A; Bouquin JP; Schewe D; Harbott J; Teigler-Schlegel A; Ratei R; Ludwig WD; Koehler R; Bartram CR; Schrappe M; Stanulla M; Cario G
    Haematologica; 2013 Mar; 98(3):428-32. PubMed ID: 22875627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.
    de Rooij JD; Beuling E; van den Heuvel-Eibrink MM; Obulkasim A; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Gibson BE; Pieters R; Zimmermann M; Zwaan CM; Fornerod M
    Haematologica; 2015 Sep; 100(9):1151-9. PubMed ID: 26069293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.
    Ofverholm I; Tran AN; Heyman M; Zachariadis V; Nordenskjöld M; Nordgren A; Barbany G
    Leukemia; 2013 Sep; 27(9):1936-9. PubMed ID: 23538749
    [No Abstract]   [Full Text] [Related]  

  • 29. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.
    Lopes BA; Meyer C; Barbosa TC; Zur Stadt U; Horstmann M; Venn NC; Heatley S; White DL; Sutton R; Pombo-de-Oliveira MS; Marschalek R; Emerenciano M
    Oncotarget; 2016 Aug; 7(33):53064-53073. PubMed ID: 27419633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.
    Caye A; Beldjord K; Mass-Malo K; Drunat S; Soulier J; Gandemer V; Baruchel A; Bertrand Y; Cavé H; Clappier E
    Haematologica; 2013 Apr; 98(4):597-601. PubMed ID: 23065506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IKZF1
    Kovach AE; Wengyn M; Vu MH; Doan A; Raca G; Bhojwani D
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30996. PubMed ID: 38637852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
    Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G
    Haematologica; 2008 Dec; 93(12):1814-21. PubMed ID: 18838475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of IKZF1 alteration status in pediatric B-lineage acute lymphoblastic leukemia: a meta-analysis.
    Feng J; Tang Y
    Leuk Lymphoma; 2013 Apr; 54(4):889-91. PubMed ID: 22916957
    [No Abstract]   [Full Text] [Related]  

  • 36. [The abnormal expression of IKZF1 encoded protein-IKAROS in B-ALL children].
    Huang XH; Chen J; Li BS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):743-7. PubMed ID: 24034916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
    Asai D; Imamura T; Yamashita Y; Suenobu S; Moriya-Saito A; Hasegawa D; Deguchi T; Hashii Y; Endo M; Hatakeyama N; Kawasaki H; Hori H; Horibe K; Yumura-Yagi K; Hara J; Watanabe A; Kikuta A; Oda M; Sato A;
    Cancer Med; 2014 Jun; 3(3):623-31. PubMed ID: 24578304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ikaros and tumor suppression in acute lymphoblastic leukemia.
    Payne KJ; Dovat S
    Crit Rev Oncog; 2011; 16(1-2):3-12. PubMed ID: 22150303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia.
    Górniak P; Pastorczak A; Zalewska-Szewczyk B; Lejman M; Trelińska J; Chmielewska M; Sokół-Jeżewska A; Kowalczyk J; Szczepanski T; Matysiak M; Kazanowska B; Mlynarski W;
    Leuk Lymphoma; 2014 Sep; 55(9):2174-8. PubMed ID: 24597983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordant B-cell precursor acute lymphoblastic leukemia in non-twinned siblings.
    Pombo-de-Oliveira MS; Emerenciano M; Winn AP; Costa I; Mansur MB; Ford AM
    Blood Cells Mol Dis; 2015 Jan; 54(1):110-5. PubMed ID: 25150625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.